pneumococcal polysaccharides conjugated to crm197 protein carrier

Ukraine

Drugs containing this active substance

  • PNEUMOSIL/PNEUMOSIL VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTION, POLYSACCHARIDE, CONJUGATED (10-VALENT, ADSORBED)

    The vaccine is used for the active immunization of infants and children aged 6 weeks to 2 years for the prevention of pneumonia, acute otitis media, and other invasive diseases caused by pneumococcus.

    Form: suspension for injection

    Active substance Dosage
    pneumococcal polysaccharides conjugated to crm197 protein carrier 2 mcg (serotypes 1, 5, 6A, 7F, 9V, 14, 19A, 19F, 23F) or 4 mcg (serotype 6B)

    ATC: J07AL02

    Manufacturer: Serum Institute of India Pvt. Ltd.